Close Menu

At a conference yesterday, Merck's Merv Turner said big pharma's problems are due to researchers, reports Science Insider. "Seventy-five cents of every dollar we spend on R&D goes to fund failure," Turner said. He added that Merck is undergoing "painful" restructuring after acquiring Schering-Plough and that one area that will likely be pared down is late-stage drug development -- though "nothing's safe from cuts."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.